2015
DOI: 10.1177/2051415815589899
|View full text |Cite
|
Sign up to set email alerts
|

Sunitinib therapy for metastatic renal cell carcinoma: A urologist’s perspective

Abstract: Previous first-line treatment was with immunotherapy (interleukin-2 or interferon α (IFN-α)) but had poor response rates of less than 20% with a significant toxicity profile. 5,6

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 12 publications
(26 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?